1. 1. GBD Diarrhoeal Diseases Collaborators (GBDDDC). Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infect Dis. 2017; 17: 909-48.
2. 2. Patrick GAD, Weill FX. Antigenic Formulae of the Salmonella Serovars [9th Edition]. 2007; WHO Collaborating Centre for Reference and Research on Salmonella, Institut Pasteur, France <https://www.pasteur.fr/sites/default/files/veng_0.pdf>.
3. 3. Hunter JC, Francois Watkins LK. Centers for Diseases Control and Prevention. October 2018. Available at <https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseasesrelated-to-travel/salmonellosis-nontyphoidal>. Accessed October, 2018.
4. 4. Olsen SJ, Bishop R, Brenner FW, et al. The changing epidemiology of Salmonella: trends in serotypes isolated from humans in the United States, 1987-1997. J Infect Dis. 2001;183:753-61.
5. 5. Wen SC, Best E, Nourse C. Non-typhoidal Salmonella infections in children: Review of literature and recommendations for management. J Paediatr Child Health. 2017;53:936-41.